conduct larg diabet survey feb consist patient
physician nurs cde one patient survey one profession stock
standpoint survey less worri volum clearli
cgm market acceler last sever month rise interest
type diabet libr us price main focu current view
price pressur manag new manufactur volum help off-set
margin standpoint investor buy share increas
confid volum rais pt base
sale assum net cash s/o closer
share three-year averag
patient survey current use cgm expect use futur
new patient come cgm half type
cgm patient survey expect
futur libr went period
compar patient believ best accuraci technolog
custom support brand reput libr lowest cost visual appeal
eas use
patient believ appeal medicar patient compar
opinion libr
cash pay basi patient view believ deserv per
month premium believ deserv premium libr
believ premium premium
next gener system patient want lower cost better accuraci longer
expect cgm type penetr go today offic
year nearli half respond believ reach
expect cgm type penetr go today year
patient interest libr type
believ dexcom market share go today year libr
go
compar physician/nurs believ best accuraci
technolog custom support brand reput wherea libr lowest cost
visual appeal eas use
medicar patient fine either let patient decid
would recommend libr
next gener system want lower cost better accuraci
develop continu glucos monitor diabet manag
sale assum
net cash fulli dilut share
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
conduct larg diabet survey consist patient
physician nurs cde certifi diabet educ total respons
patent cde physicians/nurs split survey two chapter
first patient side stori second physician/nurses/cd clear
survey cgm wave futur type interest
type grow rapidli well lose rel market share go forward
libr number patient start cgm off-set market share declin
libr grow fastest clear cost volum dynam wherea cost come
volum go faster rate medicar despit libr get approv
expect remain leader market final next gener system
patient physicians/nurs want lower cost accur system
term stock less worri volum side
cgm market clearli acceler rapidli interest type market gain traction
rise tide lift libr ship clearli zero-sum game thu
focu remain price expect pressur believ manag
success libr pharmaci channel probabl acceler price pressur
payer cover dme expect less current libr aggress use
pharmaci discount card patient pay cash push volum
pharmaci cost pharmaci still get margin price come
fall cliff low cost system come
new manufactur facil off-set remain buyer share still
incorpor meaning libr risk multipl increas confid volum
rais pt base sale assum
net cash s/o closer share three-year averag pre-libr
follow best describ
page
diabetes/famili chapter patient
patient diabet and/or famili member diabet take survey
survey heavili weight toward type nearli respond follow
type exhibit detail breakdown patient type
type diabet you/they
ask survey particip monitor glucos level today expect
chang futur survey disproport weight cgm user
current use cgm compar market rang type includ type
type mdi closer view given topic survey cgm
survey type user attract peopl alreadi familiar technolog
you/they use monitor glucos level regular basi
page
patient popul alreadi well penetr cgm patient expect util
cgm futur take share away blood glucos meter specif particip
expect use cgm futur compar current util technolog
confirm view cgm potenti standard care cost come thu
current penetr rate type type type mdi go much
higher futur would surpris see type penetr reach eventu
you/they plan monitor glucos level next year
page
currentin glucos meter finger continu glucos glucos meter finger continu glucos
interest dig deeper data specif new add type type
number type patient cgm expect doubl futur
type patient current cgm year expect type
current cgm expect year type market cours
much larger type market adopt repres massiv opportun cgm
manufactur importantli half new add cgm expect type
accord survey
current futur cgm use patient type show doubl type
page
abl ask particip cgm current use expect
use futur patient answer question current
abbott freestyl libr
cgm you/they current use
look futur year patient answer question expect still
domin market share follow abbott freestyl libr
share loser
cgm you/they plan use futur
detail shift also import drop-out new add share-tak
compani patient add follow libr libr abl take
patient wherea abl attract new patient
cgm view greater awar drive acceler adopt cgm dexcom
libr abl growth commerci base
page
current user survey look futur plan stay
two plan switch libr two plan switch two answer
futur question drop two switch libr cite cost reason switch
one user cite technolog believ mean thu
expect lose six patient current user survey said expect
new cgm user futur convert bgm expect get
patient go detail section
also expect take seven patient well thu expect add
new patient futur year exhibit bridg current futur loss
add taken togeth share shift libr still
expect grow commerci busi best brand reput attract
new entrant market thesi remain cgm adopt explod
abl win fair share
current futur user
page
current libr user survey expect grow futur see exhibit
libr expect lose zero patient add six new one new patient two
came four new cgm look four patient new cgm
choos libr half type half type similar feedback
hear market believ given low cost offer libr attract
type patient market ever
freestyl libr current futur user
page
lastli current futur user expect rel flat seven peopl
drop six peopl plan join patient current cgm plan
stay seven plan switch reason cite chang five said
accuraci two said technolog six new patient plan use two came
four new cgm
current futur user
page
ask user switch switch allow select
reason appli greatest reason switch accuraci follow
technolog cost bit surpris finger stick calibr toward lower
end patient chose accuraci technolog mostli plan user
chose cost libr dig data patient chose accuraci
technolog type type type opinion tell us
accuraci still matter patient especi type lower cost libr
attract type market ever
you/they switch main reason chang
page
insertionbest compani reputationno finger stick calibrationsmal profil bodycosttechnolog alerts/alarms/shar featur accuraci
next survey particip rank top compani segment broken
accuraci eas use best technolog custom support low cost visual appeal best brand
reput know survey heavi bia toward user need take
account draw conclus current cgm user
leader everi categori except low cost libr favorit libr well
cost visual appeal eas use domin accuraci technolog custom
support best brand reput laggard across area find
interest exhibit compani customer-fac servic matter
wherea investor tend laser-focus cost accuraci brand reput
custom support underappreci given consum natur cgm
compar follow pleas select cgm rank best follow categori
page
usebesttechnologycustomersupportlow costvisualappealbest brandreputationdexcom freestyl libr enlite/guardian freestylelibr enlite/guardian eversens accuracyeas usebest technologycustom supportlow costvisu appealbest brand reput
sinc libr got medicar approv januari curiou patient standpoint
product appeal medicar patient popul encouragingli medicar
patient said appeal follow opinion
freestyl libr thu competit medicar believ product
prefer strong growth driver
medicar abbott freestyl libr cover medicar
product appeal
cost focu investor main reason patient adopt cgm
queri patient much would will pay month ad benefit
compar libr specif ask pay basi assum insur
coverag discount card freestyl libr cost month sensor
compar sensor assum wear though
get longer enhanc featur like alerts/alarm link mobil
device/smartwatch share featur allow friends/famili follow monthli basi
much think extra featur add valu current price month
result interest shown exhibit respond said extra
fair valu provid anoth would actual will pay month
featur taken togeth believ current price fair would will pay
move cost curv patient believ featur add valu
worth extra valu price come level would impli around
sensor declin current sensor price time
believ far-fetch see price declin gradual one big hit one
year perhap best approach multi-ti price strategi want pay
futur gen verili product final said featur add extra
valu said add valu worth taken togeth respond
believ price need come current premium honestli less
would expect normal consum want everyth cheaper believ
extra featur add zero valu believ safe say libr current
form never price pariti ad worth valu proposit
view price come volum grow faster clip
page
pay basi assum insur coverag discount card freestyl libr
cost month sensor compar sensor
assum wear though get longer enhanc featur
like alerts/alarm link mobil device/smartwatch share featur allow
friends/famili follow monthli basi much think extra featur
add valu current price month
final end consum portion survey ask best thing cgm
exhibit worst thing exhibit respond want see next
gener system exhibit patient favorit thing cgm abil see glucos
trend follow alert go high/low make manag diseas easier
two respons surpris us reduc number finger stick per day abil
share data got less vote would suspect especi latter
page
featureshav featuresar nice want thosefeatur foran extra think fair fairlyvalu wile topay becausethos featur arelife-sav exhibit
best thing cgm select appli
top worst thing cgm cost follow annoy alert alarm
inaccur read expect cost top total surpris
view interest see alert alarm number two chart best
worst alert alarm necessari opinion may customiz option
patient desir recent releas updat app aim improv
experi enabl flexibl alert patient-specif need talk
import alarm note customizable/us data believ
advantag especi open architectur enabl diabet
ecosystem see prior doc call
worst thing cgm select appli
page
friends/famili follow mylevel help share diabetesreduc number finger stick dayabl see differ food activ drug affect levelsmak manag diabet easieralert go high/low see glucos wearconst remind diabetes/overburdenedtoo big bulkyi like attach someth bodyinaccur readingsannoy alerts/alarmscost much
final end featur next gener improv upon three
tie stood rest lower cost better accuraci longer last time
see clear path libr last day europ mayb someday
 lower cost improv accuraci last day interest
see fda forc shut day price sensor
believ two interconnect system shut day lower
charg rel sensor go beyond day like
charg opinion
pick one featur next gener improv upon
page
useless invasivesmal sizelong last increas numberof day per sensor better accuracylow cost
patient show interest cgm plan stay bgm ask
exhibit would need chang get interest cgm technolog exhibit
far biggest reason interest cgm technolog expens
follow fact want wear someth bodi patient
get interest cgm cost would lower along improv accuraci
similar desir current cgm patient talk next gener system thu
believ cost continu come volum interest cgm rise
you/they interest cgm select follow appli
would need chang current cgm technolog get interest
page
need itdoctor recommend ittoo mani alarmscgm hard insert stay hadskin reaction itdo want wear someth bodytoo last increasenumb ofday persensor smaller sizenoth haveno interest inadoptingeas useless invasivebetteraccuracylow cost
cgm
cde physician/nurs take survey good mix high medium
low volum practic exhibit show breakdown number patient see
year see
mani patient see year
page
want get sens industri profession saw cgm trend go futur
thu ask percent type patient cgm see
trend go forward current respond type patient cgm
market littl expect three year
year dig deeper year data respons believ reach
penetr nearli half respond believ reach confirm
belief cgm set becom standard care type cgm market growth
remain strong next decad
percent type patient cgm see trend
focus type ask cgm product patient use expect
trend futur surpris current market leader market share
follow abbott next year expect
cede share abbott freestyl libr gain expect go
share today year libr go today year market
model assum go market share year market
model assumpt assum market share declin compar profession
type patient use cgm percent use follow product
exhibit may read neg first glanc libr take market share
zero sum game cgm market set rapid growth year
better frame argument exhibit take respond cgm penetr
market share estim next year look data cgm market growth
page
market share estim impli growth compound-annual-growth-rate next year
believ would view posit street consensu
page
mdi normal cgm mdi insulin market
move beyond type ask respond type penetr adopt
next year type market much larger type market patient
nearli patient insulin mdi multipl daili inject
thu penetr market repres meaning opportun cgm manufactur
current type patient cgm higher market averag low singl
digit expect grow year year much higher old
market model assum penetr mdi insulin user given
result updat model assum penetr mdi penetr insulin
user type penetr reach rate next sever year cgm
manufactur would benefit massiv look clue partnership
see quickli could inde play
percent type patient cgm see trend
page
get type user access cgm reimburs type improv well
cash pay cost need come ask respond reimburs
coverag type chang year vs last said much better
said somewhat better say exhibit
precis breakdown main take-away reimburs continu improv
addit clinic data well lower cost system improv access go forward
would compar cgm reimburs coverag type patient year
page
bettersomewhat betterabout samesomewhat worsemuch wors
certainli expect bolu new patient cgm alway
patient start cgm stop ask common reason patient
want tri cgm stop use cgm select appli patient survey
cost main factor respons follow mani alarm
want wear someth bodi well thu
cost come reduc attrit rate well
follow common reason patient want tri cgm
stop use cgm select appli
page
see need itcgm hard insert stay hadskin reaction itthey trust accuraci itthey want wear someth ontheir bodytoo mani alarmstoo expens
get specif ask particip rank differ base accuraci
eas use best technolog custom support low cost visual appeal best brand reput
result similar patient respons question clear
winner term accuraci technolog custom support brand reput libr
winner eas use low cost visual appeal opinion jibe channel check
market feedback well cost focu point investor custom
support brand reput underestim
compar follow pleas select cgm rank best follow categori
page
usebesttechnologycustomersupportlow costvisualappealbest brandreputationdexcom freestyl libr enlite/guardian freestylelibr enlite/guardian eversens accuracyeas usebest technologycustom supportlow costvisu appealbest brand reput
dig deeper libr ask percent patient interest libr type
vs type surprisingli patient interest libr type higher
would expect europ estim flip type type
view given cost abl attract patient thu lower
cost libr final open market note penetr type
massiv market opportun cgm manufactur libr like domin type
market second gener verili product come unless reimburs
greatli improv type said decom partnership type
could also yield interest result allow access patient one largest
commerci payer
patient interest freestyl libr percent type vs type
page
look medicar specif patient ask abbott freestyl
libr medicar coverag specif patient cgm would recommend
major said fine either let patient decid wherea said
said abbott recal ask patient said
opinion abbott thu taken togeth still believ attract
lot medicar patient libr get reimburs current code
better patient hypo unawar higher preval alder
medicar abbott freestyl libr cover medicar
product appeal
page
abbott freestyl libr either fine let patient decid
continu product-specif question ask respond expect
launch no-calibr system major said summer follow fall
peopl spring baselin case summer optim approv ada
late june view import eas use visual appeal finger stick
calibr also accur sensor market option calibr
potenti safeguard close loop system well
expect launch no-calibr system
page
clear shift key outcom measur diabet cgm play key role
shift outcom made avail cgm increas time rang reduc time
spent hypoglycemia reduc time spent hyperglycemia ask particip
rank order import least import outcom measur
far reduc time spent hypoglycemia import follow increas time
rang second lower reduc time spent hyperglycemia tie third
fourth
util cgm pleas rank follow outcom measur order import import
final end profession survey need improv next gener cgm
system lower cost got vote follow better accuraci mirror patient
respons cost accuraci also longer last well thu look futur
innov cgm realli compet focu area
pick one featur next gener improv upon
page
time rangereduc time spent hypoglycemialow time spent time spentin hypoglycemiaincreas time inrangelow time spentin useless invasivesmal sizelong last increas numberof day per sensor better accuracylow cost
thousand except per share
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
